Peng Meng

952 total citations
22 papers, 649 citations indexed

About

Peng Meng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Peng Meng has authored 22 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Peng Meng's work include Pancreatic and Hepatic Oncology Research (4 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and Adipose Tissue and Metabolism (3 papers). Peng Meng is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and Adipose Tissue and Metabolism (3 papers). Peng Meng collaborates with scholars based in China, United States and Japan. Peng Meng's co-authors include Rita Ghosh, Addanki P. Kumar, Chuanxin Wang, Lutao Du, Lei Bi, Qinlian Jiao, Yidan Ren, Roble Bedolla, Robert L. Reddick and Maoxiao Feng and has published in prestigious journals such as Hepatology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Peng Meng

20 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Meng China 13 383 171 140 110 92 22 649
Di Zhou China 13 347 0.9× 122 0.7× 86 0.6× 114 1.0× 96 1.0× 36 721
Hongpeng Jiang China 14 354 0.9× 196 1.1× 140 1.0× 74 0.7× 38 0.4× 25 638
Huilai Miao China 16 428 1.1× 180 1.1× 139 1.0× 74 0.7× 127 1.4× 36 771
Linhai Zhu China 14 272 0.7× 98 0.6× 183 1.3× 138 1.3× 61 0.7× 55 605
Lizhi Lv China 13 235 0.6× 150 0.9× 100 0.7× 75 0.7× 81 0.9× 42 487
Lijun Sun China 13 272 0.7× 103 0.6× 71 0.5× 82 0.7× 150 1.6× 25 610
Haoran Qian China 9 238 0.6× 76 0.4× 203 1.4× 135 1.2× 183 2.0× 28 618
Sheng Zhao China 10 321 0.8× 182 1.1× 76 0.5× 37 0.3× 52 0.6× 22 565
Yung‐Lung Chang Taiwan 15 360 0.9× 104 0.6× 71 0.5× 51 0.5× 63 0.7× 32 566

Countries citing papers authored by Peng Meng

Since Specialization
Citations

This map shows the geographic impact of Peng Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Meng more than expected).

Fields of papers citing papers by Peng Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Meng. The network helps show where Peng Meng may publish in the future.

Co-authorship network of co-authors of Peng Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Meng. A scholar is included among the top collaborators of Peng Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Meng. Peng Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wei, et al.. (2025). The multifaceted impact of physical exercise on FoxO signaling pathways. Frontiers in Cell and Developmental Biology. 13. 1614732–1614732. 2 indexed citations
3.
Jiang, Weiwei, Yan Wang, Wanli He, et al.. (2024). CircCOCH plays a critical role in Hepatocellular carcinoma through modulating miR-450a and activating PI3K/mTOR pathway. Translational Oncology. 49. 102090–102090.
4.
Bi, Lei, Yidan Ren, Maoxiao Feng, et al.. (2021). HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness. Cancer Research. 81(8). 2015–2028. 123 indexed citations
5.
Zhang, Yaowen, Haijun Yang, Jian Li, et al.. (2021). Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resection. Translational Oncology. 14(6). 101066–101066. 9 indexed citations
6.
Meng, Peng, Yun Bian, Huan Wang, et al.. (2021). Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next‑generation sequencing. Experimental and Therapeutic Medicine. 21(5). 415–415. 2 indexed citations
7.
Zhou, Peiyang, Yan Shen, Lingyun Wang, et al.. (2020). Association between carotid intima media thickness and small dense low-density lipoprotein cholesterol in acute ischaemic stroke. Lipids in Health and Disease. 19(1). 177–177. 10 indexed citations
8.
Duan, Rui‐Sheng, et al.. (2020). Estimation of the LDL subclasses in ischemic stroke as a risk factor in a Chinese population. BMC Neurology. 20(1). 414–414. 16 indexed citations
9.
Du, Lutao, Xiaoyan Liu, Yidan Ren, et al.. (2020). Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells. Theranostics. 10(21). 9458–9476. 41 indexed citations
10.
Meng, Peng, et al.. (2019). Propagation of functional estrogen receptor positive normal human breast cells in 3D cultures. Breast Cancer Research and Treatment. 176(1). 131–140. 5 indexed citations
11.
Meng, Peng, et al.. (2019). Contextual role of E2F1 in suppression of melanoma cell motility and invasiveness. Molecular Carcinogenesis. 58(9). 1701–1710. 4 indexed citations
12.
Cai, Hui, Changqing Jing, Xusheng Chang, et al.. (2019). Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. Journal of Translational Medicine. 17(1). 189–189. 75 indexed citations
13.
Wang, Kaixuan, Wei Zhou, Peng Meng, et al.. (2019). Immune-related somatic mutation genes are enriched in PDACs with diabetes. Translational Oncology. 12(9). 1147–1154. 6 indexed citations
14.
Xu, Wangyang, Yan Shen, Houbao Zhu, et al.. (2019). 2-Aminoadipic acid protects against obesity and diabetes. Journal of Endocrinology. 243(2). 111–123. 35 indexed citations
16.
Meng, Peng, Jing Liu, Ping Hu, & Fei Tong. (2018). Protective Effect of Dexmedetomidine on Endotoxin-Induced Acute Lung Injury in Rats. Medical Science Monitor. 24. 4869–4875. 21 indexed citations
17.
Batth, Izhar Singh, Peng Meng, Paweł A. Osmulski, et al.. (2016). Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer. Oncotarget. 7(12). 14048–14063. 15 indexed citations
18.
Meng, Peng, et al.. (2015). Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells. Oncotarget. 6(9). 7195–7208. 82 indexed citations
19.
Thapa, Dinesh, Peng Meng, Roble Bedolla, et al.. (2014). NQO1 Suppresses NF-κB–p300 Interaction to Regulate Inflammatory Mediators Associated with Prostate Tumorigenesis. Cancer Research. 74(19). 5644–5655. 45 indexed citations
20.
Meng, Peng & Rita Ghosh. (2014). Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?. Cell Death and Disease. 5(8). e1360–e1360. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026